Prostate Cancer Foundation is a 501(c)(3) organization based in Santa Monica, California, registered in 1993, with $57,291,095 in FY2023 revenue. CharityIndex grades it A, and it directs about 83% of spending to programs.
Revenue (FY2023)
$57.3M
▼ 20.3% vs prior year
Philanthropy median: $168K
Expenses (FY2023)
$55.1M
Net assets
$48.0M
Employees
46
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Prostate Cancer Foundation: 83% to programs · $9 to raise $100 earns a A on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Prostate Cancer Foundation: 10 mo reserves · +4% margin earns a A on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Prostate Cancer Foundation: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Prostate Cancer Foundation: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Pcf is the leading philanthropic organization funding high risk & reward prostate cancer research.
For more than 3 million american men and their families fighting prostate cancer and millions more globally, pcf serves as a primary source for new standard-of-care and research information. pcf educates the public about prostate cancer risks, screening, prevention, treatment options, and side effects. we connect patients, loved ones, care providers, and scientists to critical updates, the latest developments, best practices, and news from the treatment pipeline. since pcf's inception, and through its efforts, patients around the world are living longer, suffering fewer complications, and enjoying better quality of life. pcf aims to spur men and women alike to talk about this disease, to understand its urgency, and to have information-driven hope.
Pcf created the young investigator award program with one goal: to build a gifted cohort of human capital supporting the next generation of prostate cancer researchers. awards are made to early-career scientists working in a research environment capable of supporting high-impact prostate cancer research, drawn from a variety of medical research disciplines. since 2007, pcf has awarded nearly $88 million to advance the early careers of 408 pcf young investigators, ensuring a continued stream of human capital into our research community. the pcf young investigator program plays an integral role in championing, mentoring, and identifying future medical research program leaders.
More than 12,000 men cared for by the department of veterans affairs (va) hospitals are newly diagnosed with prostate cancer each year, making it the most frequently diagnosed cancer among veterans. the pcf-va partnership is expanding research into prostate cancer precision oncology treatment options. the collaboration is expanding the number of precision oncology clinical studies conducted at veterans health administration hospitals, ensuring that eligible veterans can access and participate in these studies. the va's precision oncology program for cancer of the prostate (popcap) was established in partnership with the prostate cancer foundation 2016. the program uses genetic testing to find the best possible treatments for veterans with advanced prostate cancer. popcap's network extends across the u.s. it includes 21 precision oncology centers of excellence, supplemented by regional centers, that provide cancer care to any veteran who develops prostate cancer, no matter where he lives.
Revenue grew from $36.2M (FY2020) to $57.3M (FY2023) across 4 reported years.
Financial snapshot
Operating margin
3.8%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$91.8M
Total liabilities
$43.8M
Net assets
$48.0M
Salaries & benefits
$10.3M
19% of expenses
Board members
34
32 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2023 | $57,291,095▼20.3% | $55,134,763▼10.3% | $47,982,425▲5.7% | $91,770,978▲5.1% | 990 |
| 2022 | $71,921,851▲35.7% | $61,472,068▲47.5% | $45,375,641▲32.3% | $87,285,836▲39.6% | 990 |
| 2021 | $53,016,750▲46.6% | $41,671,787▲19.2% | $34,301,785▲49.1% | $62,542,873▲45.0% | 990 |
| 2020 | $36,156,917 | $34,952,661 | $23,003,373 | $43,129,058 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: Charles Ryan — $721,046 (1.31% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Charles Ryan | Ceo | 60 | $721,046 |
| Gina Carithers | Evp, President | 50 | $624,635 |
| Howard Soule | Evp, Chief Science Officer | 50 | $582,696 |
| William Oh | Evp, Chief Medical Officer | 50 | $551,617 |
| Helen Hsieh | Evp, Finance | 50 | $359,883 |
| Kari J Kalstad | Vp, Operations | 50 | $274,286 |
| Jan Haber | Vp, Events | 50 | $255,992 |
| Melanie Ranen | Vp, Development | 50 | $250,186 |
| Stuart Holden Md | Director/medical Director | 30 | $225,000 |
| George Chong | Controller | 50 | $216,269 |
| Christopher Conway | Vp, Sports | 50 | $205,056 |
| The Reverend Rosey Grier | Director | 10 | $42,000 |
| David A Ederer | Director | 2 | — |
| David Drew Pinsky | Director | 2 | — |
| David Taglight | Director | 2 | — |
| Emilio Bassini | Director | 2 | — |
| Freda Lewis-hall Md | Director | 2 | — |
| Gregory Brown | Director | 2 | — |
| Henry L Nordhoff | Director | 2 | — |
| Howard Shore | Director | 2 | — |
| Contractor | Services | Paid |
|---|---|---|
| Vision Matrix Productions Inc | Event Productions | $1,516,269 |
| Boulle Event Management | Outreach Program Mgmt | $196,665 |
| Helmsbriscoe Resourceone | Event Management | $113,380 |
213 grants to Prostate Cancer Foundation totaling $39.9M, reported by foundations on their Schedule I filings — showing the 15 most recent.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| American Cancer Society Inc | Patient support | 2024 | $300,000 |
| Paypal Charitable Giving Fund | General support | 2024 | $251,705 |
| American Online Giving Foundation Inc | General support | 2024 | $152,289 |
| American Endowment Foundation | Philanthropy | 2024 | $132,750 |
| Ayco Charitable Foundation | Medical / public services | 2024 | $128,000 |
| Greater Horizons | Health, medicine & science | 2024 | $102,000 |
| American Gift Fund | Operations | 2024 | $61,986 |
| National Christian Charitable Foundation | Medical research | 2024 | $48,500 |
| T Rowe Price Program For Charitable Giving Inc | Multiple | 2024 | $47,875 |
| Jewish Community Fdn of the Jewish Federation Council of Greater La | General support | 2024 | $28,350 |
| Columbus Foundation | Health | 2024 | $27,900 |
| Gs Donor Advised Philanthropy Fund For Wealth Management Inc | Medical / public services | 2024 | $27,000 |
| Arizona Community Foundation | This award is designated support for pcf's 2025 indian wells pro-am invitational | 2024 | $26,000 |
| The Us Charitable Gift Trust | For recipient's exempt purpose | 2024 | $25,250 |
| Jewish Communal Fund | In furtherance of grantee's tax-exempt purpose | 2024 | $15,372 |
28 grants totaling $22.9M in FY2023 — showing the 15 largest. All grants made by Prostate Cancer Foundation →
| Recipient | Purpose | Amount |
|---|---|---|
| Md Anderson Cancer Center | Cancer research | $6,450,000 |
| University of California San Francisco | Cancer research | $2,546,665 |
| Johns Hopkins University | Cancer research | $2,300,000 |
| Bronx Veterans Medical Research Foundation Inc | Cancer research | $1,417,233 |
| Icahn School of Medicine At Mount Sinai | Cancer research | $1,225,000 |
| Regents of the University of Michigan | Cancer research | $1,224,417 |
| University of California San Diego | Cancer research | $1,050,000 |
| Duke University | Cancer research | $990,670 |
| Dana-farber Cancer Institute | Cancer research | $950,000 |
| Trustees of Columbia University | Cancer research | $650,000 |
| Fred Hutchinson Cancer Research Institute | Cancer research | $649,556 |
| Memorial Sloan-kettering Cancer Center | Cancer research | $450,000 |
| Regents Univ of California | Cancer research | $444,731 |
| Baltimore Research & Education Foundation Inc | Cancer research | $250,000 |
| Mass General Brigham Incorporated | Cancer research | $225,000 |
Explore more
Data for Prostate Cancer Foundation (EIN 95-4418411) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.